G Kees Kornelis Hovingh (G Kees Hovingh, G Kees Hovingh)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Low Density Lipoprotein

Cardiovascular Disease

Coronary Artery Disease

Top Venues

Journal of the American Heart Association

Circulation. Genomic and precision medicine

Arteriosclerosis, thrombosis, and vascular biology

Expert review of clinical immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Jordan M Kraaijenhof, Héléne Toinét Cronjé, G Kees Kornelis Hovingh, Nick S Nurmohamed, Dipender Gill, Loukas Zagkos
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition. Journal of the American Heart Association 13 (12) (2024)
Jordan M Kraaijenhof, Héléne Toinét Cronjé, G Kees Kornelis Hovingh, Nick S Nurmohamed, Dipender Gill, Loukas Zagkos
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition. Journal of the American Heart Association 13 (12) (2024)
Jordan M Kraaijenhof, Héléne Toinét Cronjé, G Kees Kornelis Hovingh, Nick S Nurmohamed, Dipender Gill, Loukas Zagkos
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition. Journal of the American Heart Association 13 (12) (2024)
Jordan M Kraaijenhof, Héléne Toinét Cronjé, G Kees Kornelis Hovingh, Nick S Nurmohamed, Dipender Gill, Loukas Zagkos
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition. Journal of the American Heart Association (2024)
Jordan M Kraaijenhof, Héléne Toinét Cronjé, G Kees Kornelis Hovingh, Nick S Nurmohamed, Dipender Gill, Loukas Zagkos
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition. Journal of the American Heart Association 13 (12) (2024)
Jordan M Kraaijenhof, Héléne Toinét Cronjé, G Kees Kornelis Hovingh, Nick S Nurmohamed, Dipender Gill, Loukas Zagkos
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition. Journal of the American Heart Association 13 (12) (2024)
Shirin Ibrahim, Nick S Nurmohamed, Didier Collard, Anouk de Weger, G Kees Kornelis Hovingh, Bert-Jan H Van Den Born, Laurens F Reeskamp, Erik S G Stroes, Tom F Brouwer
Association Between Self-Rated Medication Adherence and Adverse Cardiovascular Outcomes in Patients With Hypertension. Journal of the American Heart Association (2023)
Jordan M Kraaijenhof, Tjerk S J Opstal, Jan-Hein Cornel, Dipender Gill, G Kees Kornelis Hovingh, Alberico Luigi Catapano, Wolfgang Koenig, Paul M Ridker, Erik S G Stroes, Nick S Nurmohamed
Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy. Arteriosclerosis, thrombosis, and vascular biology (2023)
Shirin Ibrahim, Jeroen van Rooij, Annemieke J M H Verkerk, Jard de Vries, Linda Zuurbier, Joep Defesche, Jorge Peter, Willemijn A M Schonck, Bahareh Sedaghati-Khayat, G Kees Kornelis Hovingh, Andre G Uitterlinden, Erik S G Stroes, Laurens F Reeskamp
Low-Cost High-Throughput Genotyping for Diagnosing Familial Hypercholesterolemia. Circulation. Genomic and precision medicine (2023)
Jordan M Kraaijenhof, Tycho R Tromp, Nick S Nurmohamed, Laurens F Reeskamp, Marije Langenkamp, Johannes H M Levels, S Matthijs Boekholdt, Nicholas J Wareham, Menno Hoekstra, Erik S G Stroes, G Kees Kornelis Hovingh, Aldo Grefhorst
ANGPTL3 (Angiopoietin-Like 3) Preferentially Resides on High-Density Lipoprotein in the Human Circulation, Affecting Its Activity. Journal of the American Heart Association (2023)
Frederik Flindt Kreiner, Jordan M Kraaijenhof, Matthias von Herrath, G Kees Kornelis Hovingh, Bernt Johan von Scholten
Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives. Expert review of clinical immunology 18 (4) (2022)
Arjen J Cupido, Folkert W. Asselbergs, Amand Floriaan Schmidt, G Kees Kornelis Hovingh
Low-Density Lipoprotein Cholesterol Attributable Cardiovascular Disease Risk Is Sex Specific. Journal of the American Heart Association 11 (12) (2022)
Arjen J Cupido, Folkert W. Asselbergs, Pradeep Natarajan, null null, Paul M Ridker, G Kees Kornelis Hovingh, Amand Floriaan Schmidt
Dissecting the IL-6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R. British journal of clinical pharmacology 88 (6) (2022)
Arjen J Cupido, Jordan M Kraaijenhof, Stephen Burgess, Folkert W. Asselbergs, G Kees Kornelis Hovingh, Dipender Gill
Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian Randomization. Circulation. Genomic and precision medicine 15 (1) (2022)
Tycho R Tromp, G Kees Kornelis Hovingh, Laurens F Reeskamp
Letter by Tromp et al Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland". Arteriosclerosis, thrombosis, and vascular biology 42 (1) (2021)